Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease

Affiliations

¹ University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
² Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile.
³ Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; European Association for the Study of the Liver (EASL), Geneva, Switzerland. Electronic address: Aleksander.Krag@rsyd.dk.
⁴ Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; American Association for the Study of Liver Diseases (AASLD), Alexandria, USA.
⁵ National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Comment

Mary E Rinella et al. J Hepatol. 2024 Jul.

. 2024 Jul;81(1):e20-e21.

doi: 10.1016/j.jhep.2023.10.008. Epub 2023 Dec 19.

¹ University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
² Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile.
³ Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; European Association for the Study of the Liver (EASL), Geneva, Switzerland. Electronic address: Aleksander.Krag@rsyd.dk.
⁴ Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; American Association for the Study of Liver Diseases (AASLD), Alexandria, USA.
⁵ National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

No abstract available

Comment on

From NAFLD to MASLD: Promise and pitfalls of a new definition.
Cusi K, Younossi Z, Roden M. Cusi K, et al. J Hepatol. 2024 Jul;81(1):e18-e19. doi: 10.1016/j.jhep.2023.09.038. Epub 2023 Dec 19. J Hepatol. 2024. PMID: 38906626 No abstract available.